Selected Cell
Cell:
Value:
Sheet1
A
B
C
D
E
F
G
H
I
J
2201
2202
2203
2204
2205
2206
2207
2208
2209
2210
2211
2212
2213
2214
2215
2216
2217
2218
2219
2220
2221
2222
2223
2224
2225
2226
2227
2228
2229
2230
2231
2232
2233
2234
2235
2236
2237
2238
2239
2240
2241
2242
2243
2244
2245
2246
2247
2248
2249
2250
2251
2252
2253
2254
2255
2256
2257
2258
2259
2260
2261
2262
2263
2264
2265
2266
2267
2268
2269
2270
2271
2272
2273
2274
2275
2276
2277
2278
2279
2280
2281
2282
2283
2284
2285
2286
2287
2288
2289
2290
2291
2292
2293
2294
2295
2296
2297
2298
2299
2300
2301
2302
2303
2304
2305
2306
2307
2308
2309
2310
2311
2312
2313
2314
2315
2316
2317
2318
2319
2320
2321
2322
2323
2324
2325
2326
2327
2328
2329
2330
2331
2332
2333
2334
2335
2336
2337
2338
2339
2340
2341
2342
2343
2344
2345
2346
2347
2348
2349
2350
2351
2352
2353
2354
2355
2356
2357
2358
2359
2360
2361
2362
2363
2364
2365
2366
2367
2368
2369
2370
2371
2372
2373
2374
2375
2376
2377
2378
2379
2380
2381
2382
2383
2384
2385
2386
2387
2388
2389
2390
2391
2392
2393
2394
2395
2396
2397
2398
2399
2400
| "REAC" | "Transcription of E2F targets under negative control by DREAM complex" | "REAC:R-HSA-1362277" | "0.00007621052932772151" | "4.117985021927859" | "19" | "549" | "9" | "10531" | "E2F1 |
| "REAC" | "Activation of BH3-only proteins" | "REAC:R-HSA-114452" | "0.00007646612527875244" | "4.1165309159924615" | "30" | "549" | "11" | "10531" | "BCL2 |
| "REAC" | "Transcriptional Regulation by MECP2" | "REAC:R-HSA-8986944" | "0.00011043569594626382" | "3.9568905276323036" | "59" | "549" | "15" | "10531" | "PTEN |
| "REAC" | "S Phase" | "REAC:R-HSA-69242" | "0.00011328767892183635" | "3.9458173210918632" | "161" | "549" | "26" | "10531" | "WEE1 |
| "REAC" | "Signaling by MET" | "REAC:R-HSA-6806834" | "0.00012972053589622702" | "3.8869912658555745" | "76" | "549" | "17" | "10531" | "CRK |
| "REAC" | "Platelet Aggregation (Plug Formation)" | "REAC:R-HSA-76009" | "0.00013775079556933498" | "3.860905884233895" | "38" | "549" | "12" | "10531" | "CRK |
| "REAC" | "Cellular responses to stress" | "REAC:R-HSA-2262752" | "0.00014856848799515564" | "3.828073296504718" | "545" | "549" | "57" | "10531" | "E2F3 |
| "REAC" | "Cellular responses to external stimuli" | "REAC:R-HSA-8953897" | "0.00015198791841746566" | "3.818190932931303" | "559" | "549" | "58" | "10531" | "E2F3 |
| "REAC" | "Signaling by ERBB4" | "REAC:R-HSA-1236394" | "0.0002158074755949414" | "3.6659335153834145" | "54" | "549" | "14" | "10531" | "ITCH |
| "REAC" | "Signaling by WNT" | "REAC:R-HSA-195721" | "0.00021771336562071566" | "3.6621149084088596" | "292" | "549" | "37" | "10531" | "SOX2 |
| "REAC" | "Constitutive Signaling by Aberrant PI3K in Cancer" | "REAC:R-HSA-2219530" | "0.00022271819402325247" | "3.6522443036612877" | "62" | "549" | "15" | "10531" | "PIK3R2 |
| "REAC" | "Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1" | "REAC:R-HSA-1362300" | "0.00022789823221878357" | "3.642259043580507" | "16" | "549" | "8" | "10531" | "E2F1 |
| "REAC" | "Binding of TCF/LEF:CTNNB1 to target gene promoters" | "REAC:R-HSA-4411364" | "0.00024766715756164816" | "3.606131580153823" | "8" | "549" | "6" | "10531" | "AXIN2 |
| "REAC" | "RUNX3 regulates p14-ARF" | "REAC:R-HSA-8951936" | "0.00024766715756164816" | "3.606131580153823" | "8" | "549" | "6" | "10531" | "CCND1 |
| "REAC" | "RUNX3 regulates WNT signaling" | "REAC:R-HSA-8951430" | "0.00024766715756164816" | "3.606131580153823" | "8" | "549" | "6" | "10531" | "CCND1 |
| "REAC" | "MAP kinase activation" | "REAC:R-HSA-450294" | "0.00027848987388158806" | "3.5551905915038993" | "63" | "549" | "15" | "10531" | "CHUK |
| "REAC" | "Collagen formation" | "REAC:R-HSA-1474290" | "0.00028831637417911325" | "3.540130692285052" | "89" | "549" | "18" | "10531" | "MMP7 |
| "REAC" | "Pre-NOTCH Expression and Processing" | "REAC:R-HSA-1912422" | "0.00039160985667338117" | "3.4071463857019255" | "73" | "549" | "16" | "10531" | "E2F3 |
| "REAC" | "Signaling by NTRK1 (TRKA)" | "REAC:R-HSA-187037" | "0.0005601374535902314" | "3.2517053872603014" | "112" | "549" | "20" | "10531" | "CRK |
| "REAC" | "Cell Cycle" | "REAC:R-HSA-1640170" | "0.0005750258733597225" | "3.240312613737231" | "624" | "549" | "61" | "10531" | "WEE1 |
| "REAC" | "Crosslinking of collagen fibrils" | "REAC:R-HSA-2243919" | "0.000705957961370906" | "3.1512211596963873" | "18" | "549" | "8" | "10531" | "COL4A4 |
| "REAC" | "Regulation of MECP2 expression and activity" | "REAC:R-HSA-9022692" | "0.0007881490501745357" | "3.1033916434912787" | "30" | "549" | "10" | "10531" | "AGO1 |
| "REAC" | "MET activates PTK2 signaling" | "REAC:R-HSA-8874081" | "0.0007881490501745357" | "3.1033916434912787" | "30" | "549" | "10" | "10531" | "MET |
| "REAC" | "TP53 Regulates Transcription of Cell Death Genes" | "REAC:R-HSA-5633008" | "0.0008048254827895597" | "3.0942982812199538" | "44" | "549" | "12" | "10531" | "TP53INP1 |
| "REAC" | "Interleukin-2 family signaling" | "REAC:R-HSA-451927" | "0.0008048254827895597" | "3.0942982812199538" | "44" | "549" | "12" | "10531" | "PIK3R2 |
| "REAC" | "Regulation of TP53 Expression and Degradation" | "REAC:R-HSA-6806003" | "0.0008570144182032338" | "3.067011871550046" | "37" | "549" | "11" | "10531" | "MTOR |
| "REAC" | "MAPK1/MAPK3 signaling" | "REAC:R-HSA-5684996" | "0.0009665860681447245" | "3.0147594688407064" | "237" | "549" | "31" | "10531" | "SPRED1 |
| "REAC" | "Signaling by RAS mutants" | "REAC:R-HSA-6802949" | "0.0010461663688025103" | "2.9803992453851023" | "45" | "549" | "12" | "10531" | "FGG |
| "REAC" | "Signaling downstream of RAS mutants" | "REAC:R-HSA-9649948" | "0.0010461663688025103" | "2.9803992453851023" | "45" | "549" | "12" | "10531" | "FGG |
| "REAC" | "Signaling by moderate kinase activity BRAF mutants" | "REAC:R-HSA-6802946" | "0.0010461663688025103" | "2.9803992453851023" | "45" | "549" | "12" | "10531" | "FGG |
| "REAC" | "Paradoxical activation of RAF signaling by kinase inactive BRAF" | "REAC:R-HSA-6802955" | "0.0010461663688025103" | "2.9803992453851023" | "45" | "549" | "12" | "10531" | "FGG |
| "REAC" | "Transcriptional regulation of granulopoiesis" | "REAC:R-HSA-9616222" | "0.0011067746941576685" | "2.9559407793407404" | "53" | "549" | "13" | "10531" | "CDKN1A |
| "REAC" | "Nuclear signaling by ERBB4" | "REAC:R-HSA-1251985" | "0.0011096506440278187" | "2.9548137304496356" | "31" | "549" | "10" | "10531" | "ESR1 |
| "REAC" | "Regulation of gene expression in beta cells" | "REAC:R-HSA-210745" | "0.0011639560937659508" | "2.934063401640431" | "19" | "549" | "8" | "10531" | "FOXO1 |
| "REAC" | "GRB2:SOS provides linkage to MAPK signaling for Integrins " | "REAC:R-HSA-354194" | "0.0012422663056486022" | "2.9057852941141364" | "14" | "549" | "7" | "10531" | "FGG |
| "REAC" | "AKT phosphorylates targets in the cytosol" | "REAC:R-HSA-198323" | "0.0012422663056486022" | "2.9057852941141364" | "14" | "549" | "7" | "10531" | "CDKN1A |
| "REAC" | "Interleukin-7 signaling" | "REAC:R-HSA-1266695" | "0.001271027491395793" | "2.895845055872135" | "25" | "549" | "9" | "10531" | "PIK3R2 |
| "REAC" | "Interleukin-17 signaling" | "REAC:R-HSA-448424" | "0.0014159412386465769" | "2.8489547694294886" | "71" | "549" | "15" | "10531" | "CHUK |
| "REAC" | "Regulation of beta-cell development" | "REAC:R-HSA-186712" | "0.0015273454598973874" | "2.816062721713329" | "39" | "549" | "11" | "10531" | "KAT2B |
| "REAC" | "TCF dependent signaling in response to WNT" | "REAC:R-HSA-201681" | "0.001657317821870099" | "2.7805941994570627" | "196" | "549" | "27" | "10531" | "SOX2 |
| "REAC" | "AKT phosphorylates targets in the nucleus" | "REAC:R-HSA-198693" | "0.001697202534910411" | "2.7702663282507074" | "10" | "549" | "6" | "10531" | "FOXO1 |
| "REAC" | "Signaling by PDGFRA transmembrane | juxtamembrane and kinase domain mutants" | "REAC:R-HSA-9673767" | "0.001697202534910411" | "2.7702663282507074" | "10" | "549" | "6" | "10531" |
| "REAC" | "Signaling by PDGFRA extracellular domain mutants" | "REAC:R-HSA-9673770" | "0.001697202534910411" | "2.7702663282507074" | "10" | "549" | "6" | "10531" | "PIK3R2 |
| "REAC" | "Signaling by NOTCH1" | "REAC:R-HSA-1980143" | "0.0017040852348827506" | "2.7685086864980333" | "72" | "549" | "15" | "10531" | "ITCH |
| "REAC" | "Oncogenic MAPK signaling" | "REAC:R-HSA-6802957" | "0.0017040852348827506" | "2.7685086864980333" | "72" | "549" | "15" | "10531" | "SPRED1 |
| "REAC" | "Interleukin-3 | Interleukin-5 and GM-CSF signaling" | "REAC:R-HSA-512988" | "0.0017271426332907077" | "2.7626717954416833" | "47" | "549" | "12" | "10531" |
| "REAC" | "Activation of Matrix Metalloproteinases" | "REAC:R-HSA-1592389" | "0.0021066635757025025" | "2.6764048136475616" | "33" | "549" | "10" | "10531" | "MMP7 |
| "REAC" | "SUMOylation of DNA methylation proteins" | "REAC:R-HSA-4655427" | "0.0022247877222821484" | "2.652711420835656" | "15" | "549" | "7" | "10531" | "DNMT1 |
| "REAC" | "Regulation of signaling by CBL" | "REAC:R-HSA-912631" | "0.0028555530335170978" | "2.5443097696788795" | "21" | "549" | "8" | "10531" | "CRK |
| "REAC" | "Senescence-Associated Secretory Phenotype (SASP)" | "REAC:R-HSA-2559582" | "0.0029084734805490137" | "2.5363348917431217" | "75" | "549" | "15" | "10531" | "CDK6 |
| "REAC" | "DDX58/IFIH1-mediated induction of interferon-alpha/beta" | "REAC:R-HSA-168928" | "0.0034526562996430627" | "2.461846652058227" | "76" | "549" | "15" | "10531" | "ITCH |
| "REAC" | "Costimulation by the CD28 family" | "REAC:R-HSA-388841" | "0.003474951459097881" | "2.459051257604277" | "67" | "549" | "14" | "10531" | "PIK3R2 |
| "REAC" | "Interleukin-6 signaling" | "REAC:R-HSA-1059683" | "0.0035693209835263723" | "2.447414394855765" | "11" | "549" | "6" | "10531" | "JAK1 |
| "REAC" | "AKT-mediated inactivation of FOXO1A" | "REAC:R-HSA-211163" | "0.003618682803714796" | "2.4414494833835683" | "4" | "549" | "4" | "10531" | "FOXO1 |
| "REAC" | "FOXO-mediated transcription of cell death genes" | "REAC:R-HSA-9614657" | "0.0037779239923314296" | "2.4227467838528036" | "16" | "549" | "7" | "10531" | "BCL2L11 |
| "REAC" | "Signaling by high-kinase activity BRAF mutants" | "REAC:R-HSA-6802948" | "0.0038011897820088053" | "2.4200804468342465" | "35" | "549" | "10" | "10531" | "FGG |
| "REAC" | "Regulation of PTEN gene transcription" | "REAC:R-HSA-8943724" | "0.0039905217826066335" | "2.398970314215233" | "59" | "549" | "13" | "10531" | "MTOR |
| "REAC" | "PTEN Regulation" | "REAC:R-HSA-6807070" | "0.004316710488529419" | "2.364847077461486" | "138" | "549" | "21" | "10531" | "PTEN |
| "REAC" | "Regulation of TP53 Degradation" | "REAC:R-HSA-6804757" | "0.005020253500343398" | "2.2992743523727834" | "36" | "549" | "10" | "10531" | "MTOR |
| "REAC" | "RAF/MAP kinase cascade" | "REAC:R-HSA-5673001" | "0.005092396919449738" | "2.293077753249204" | "232" | "549" | "29" | "10531" | "SPRED1 |
| "REAC" | "Diseases of programmed cell death" | "REAC:R-HSA-9645723" | "0.006270441597626788" | "2.2027018727802603" | "23" | "549" | "8" | "10531" | "APP |
| "REAC" | "Signaling by Erythropoietin" | "REAC:R-HSA-9006335" | "0.006270441597626788" | "2.2027018727802603" | "23" | "549" | "8" | "10531" | "PIK3CG |
| "REAC" | "Growth hormone receptor signaling" | "REAC:R-HSA-982772" | "0.006270441597626788" | "2.2027018727802603" | "23" | "549" | "8" | "10531" | "SOCS1 |
| "REAC" | "Apoptotic cleavage of cellular proteins" | "REAC:R-HSA-111465" | "0.006562193901136066" | "2.1829509411323413" | "37" | "549" | "10" | "10531" | "APC |
| "REAC" | "Molecules associated with elastic fibres" | "REAC:R-HSA-2129379" | "0.006562193901136066" | "2.1829509411323413" | "37" | "549" | "10" | "10531" | "ITGB8 |
| "REAC" | "TP53 Regulates Transcription of Death Receptors and Ligands" | "REAC:R-HSA-6803211" | "0.006824380923010785" | "2.16593673973261" | "12" | "549" | "6" | "10531" | "TP53 |
| "REAC" | "Regulation of localization of FOXO transcription factors" | "REAC:R-HSA-9614399" | "0.006824380923010785" | "2.16593673973261" | "12" | "549" | "6" | "10531" | "FOXO1 |
| "REAC" | "NR1H2 and NR1H3-mediated signaling" | "REAC:R-HSA-9024446" | "0.006953094062462517" | "2.1578218953760544" | "45" | "549" | "11" | "10531" | "MYLIP |
| "REAC" | "Transcriptional regulation by RUNX1" | "REAC:R-HSA-8878171" | "0.007262208593132992" | "2.138931280960777" | "200" | "549" | "26" | "10531" | "CDK6 |
| "REAC" | "Interleukin-6 family signaling" | "REAC:R-HSA-6783589" | "0.008979370689172808" | "2.046754099390227" | "24" | "549" | "8" | "10531" | "JAK1 |
| "REAC" | "Transcriptional regulation of white adipocyte differentiation" | "REAC:R-HSA-381340" | "0.009066185910583039" | "2.042575379573326" | "82" | "549" | "15" | "10531" | "EGR2 |
| "REAC" | "Regulation of TP53 Activity through Phosphorylation" | "REAC:R-HSA-6804756" | "0.009322430857444301" | "2.0304708290277182" | "92" | "549" | "16" | "10531" | "TP53INP1 |
| "REAC" | "Signaling by PDGFR in disease" | "REAC:R-HSA-9671555" | "0.00958960070282681" | "2.0181994758501114" | "18" | "549" | "7" | "10531" | "PIK3R2 |
| "REAC" | "Signaling by BRAF and RAF fusions" | "REAC:R-HSA-6802952" | "0.010189637428772012" | "1.9918412689361669" | "64" | "549" | "13" | "10531" | "BCL2L11 |
| "REAC" | "MAP2K and MAPK activation" | "REAC:R-HSA-5674135" | "0.01089777833964849" | "1.9626620298735078" | "39" | "549" | "10" | "10531" | "FGG |
| "REAC" | "Signaling by NOTCH1 in Cancer" | "REAC:R-HSA-2644603" | "0.01449734789796452" | "1.8387114390495674" | "57" | "549" | "12" | "10531" | "KAT2B |
| "REAC" | "Signaling by NOTCH1 PEST Domain Mutants in Cancer" | "REAC:R-HSA-2644602" | "0.01449734789796452" | "1.8387114390495674" | "57" | "549" | "12" | "10531" | "KAT2B |
| "REAC" | "Constitutive Signaling by NOTCH1 PEST Domain Mutants" | "REAC:R-HSA-2644606" | "0.01449734789796452" | "1.8387114390495674" | "57" | "549" | "12" | "10531" | "KAT2B |
| "REAC" | "Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer" | "REAC:R-HSA-2894858" | "0.01449734789796452" | "1.8387114390495674" | "57" | "549" | "12" | "10531" | "KAT2B |
| "REAC" | "Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants" | "REAC:R-HSA-2894862" | "0.01449734789796452" | "1.8387114390495674" | "57" | "549" | "12" | "10531" | "KAT2B |
| "REAC" | "Interleukin-1 family signaling" | "REAC:R-HSA-446652" | "0.014645537381980047" | "1.8342946883219615" | "138" | "549" | "20" | "10531" | "APP |
| "REAC" | "RUNX3 regulates BCL2L11 (BIM) transcription" | "REAC:R-HSA-8952158" | "0.017344033519657083" | "1.7608498958089096" | "5" | "549" | "4" | "10531" | "BCL2L11 |
| "REAC" | "Nuclear Receptor transcription pathway" | "REAC:R-HSA-383280" | "0.01748761433577462" | "1.7572694330299987" | "41" | "549" | "10" | "10531" | "ESR1 |
| "REAC" | "SUMOylation of transcription cofactors" | "REAC:R-HSA-3899300" | "0.01748761433577462" | "1.7572694330299987" | "41" | "549" | "10" | "10531" | "NRIP1 |
| "REAC" | "Death Receptor Signalling" | "REAC:R-HSA-73887" | "0.018104412880138997" | "1.7422155546387568" | "140" | "549" | "20" | "10531" | "BCL2L11 |
| "REAC" | "Signaling by Leptin" | "REAC:R-HSA-2586552" | "0.019800656760910883" | "1.7033204045410362" | "9" | "549" | "5" | "10531" | "IRS1 |
| "REAC" | "Activation of PUMA and translocation to mitochondria" | "REAC:R-HSA-139915" | "0.019800656760910883" | "1.7033204045410362" | "9" | "549" | "5" | "10531" | "E2F1 |
| "REAC" | "Interleukin-9 signaling" | "REAC:R-HSA-8985947" | "0.019800656760910883" | "1.7033204045410362" | "9" | "549" | "5" | "10531" | "JAK1 |
| "REAC" | "PI3K/AKT activation" | "REAC:R-HSA-198203" | "0.019800656760910883" | "1.7033204045410362" | "9" | "549" | "5" | "10531" | "PIK3R2 |
| "REAC" | "Regulation of TP53 Activity through Association with Co-factors" | "REAC:R-HSA-6804759" | "0.020272059562987322" | "1.6931021264228123" | "14" | "549" | "6" | "10531" | "TP53 |
| "REAC" | "TP53 Regulates Transcription of Genes Involved in Cytochrome C Release" | "REAC:R-HSA-6803204" | "0.02131758510400661" | "1.6712619945519247" | "20" | "549" | "7" | "10531" | "TP53INP1 |
| "REAC" | "Transcriptional Regulation by E2F6" | "REAC:R-HSA-8953750" | "0.021403179860243572" | "1.6695216989328192" | "34" | "549" | "9" | "10531" | "E2F1 |
| "REAC" | "Deubiquitination" | "REAC:R-HSA-5688426" | "0.021594208438859504" | "1.6656627109003903" | "276" | "549" | "31" | "10531" | "PTEN |
| "REAC" | "VEGFR2 mediated vascular permeability" | "REAC:R-HSA-5218920" | "0.02358802577959969" | "1.6273084062489973" | "27" | "549" | "8" | "10531" | "MTOR |
| "REAC" | "Apoptotic execution phase" | "REAC:R-HSA-75153" | "0.024537696445180158" | "1.6101662104804253" | "51" | "549" | "11" | "10531" | "APC |
| "REAC" | "IRS-related events triggered by IGF1R" | "REAC:R-HSA-2428928" | "0.02721771607249317" | "1.565148320673051" | "43" | "549" | "10" | "10531" | "PIK3R2 |
| "REAC" | "IGF1R signaling cascade" | "REAC:R-HSA-2428924" | "0.02721771607249317" | "1.565148320673051" | "43" | "549" | "10" | "10531" | "PIK3R2 |
| "REAC" | "Nervous system development" | "REAC:R-HSA-9675108" | "0.03006677566509587" | "1.521913142765397" | "574" | "549" | "52" | "10531" | "EGR2 |
| "REAC" | "Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models" | "REAC:R-HSA-8862803" | "0.030548601139251313" | "1.5150086718834044" | "21" | "549" | "7" | "10531" | "APP |
| "REAC" | "ZBP1(DAI) mediated induction of type I IFNs" | "REAC:R-HSA-1606322" | "0.030548601139251313" | "1.5150086718834044" | "21" | "549" | "7" | "10531" | "CHUK |
| "REAC" | "Neurodegenerative Diseases" | "REAC:R-HSA-8863678" | "0.030548601139251313" | "1.5150086718834044" | "21" | "549" | "7" | "10531" | "APP |
| "REAC" | "Anchoring fibril formation" | "REAC:R-HSA-2214320" | "0.03230357412345756" | "1.4907494239158996" | "15" | "549" | "6" | "10531" | "COL4A4 |
| "REAC" | "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)" | "REAC:R-HSA-2404192" | "0.033602580092634594" | "1.473627375081147" | "44" | "549" | "10" | "10531" | "PIK3R2 |
| "REAC" | "CASP8 activity is inhibited" | "REAC:R-HSA-5218900" | "0.037904110986911405" | "1.4213136849631047" | "10" | "549" | "5" | "10531" | "CASP8 |
| "REAC" | "Regulation of FOXO transcriptional activity by acetylation" | "REAC:R-HSA-9617629" | "0.037904110986911405" | "1.4213136849631047" | "10" | "549" | "5" | "10531" | "KAT2B |
| "REAC" | "Regulation by c-FLIP" | "REAC:R-HSA-3371378" | "0.037904110986911405" | "1.4213136849631047" | "10" | "549" | "5" | "10531" | "CASP8 |
| "REAC" | "Dimerization of procaspase-8" | "REAC:R-HSA-69416" | "0.037904110986911405" | "1.4213136849631047" | "10" | "549" | "5" | "10531" | "CASP8 |
| "REAC" | "Innate Immune System" | "REAC:R-HSA-168249" | "0.03850208431470019" | "1.4145157592740791" | "1073" | "549" | "84" | "10531" | "ITCH |
| "REAC" | "Insulin receptor signalling cascade" | "REAC:R-HSA-74751" | "0.04121671895839809" | "1.3849265830317439" | "45" | "549" | "10" | "10531" | "PIK3R2 |
| "REAC" | "Transcriptional regulation of pluripotent stem cells" | "REAC:R-HSA-452723" | "0.042805563553623166" | "1.368499780902478" | "22" | "549" | "7" | "10531" | "SOX2 |
| "REAC" | "MAP3K8 (TPL2)-dependent MAPK1/3 activation" | "REAC:R-HSA-5684264" | "0.04941896420213326" | "1.3061063614432897" | "16" | "549" | "6" | "10531" | "CHUK |
| "REAC" | "Signaling by cytosolic FGFR1 fusion mutants" | "REAC:R-HSA-1839117" | "0.04941896420213326" | "1.3061063614432897" | "16" | "549" | "6" | "10531" | "STAT3 |
| "REAC" | "RUNX3 regulates CDKN1A transcription" | "REAC:R-HSA-8941855" | "0.049880781927366426" | "1.3020667471726688" | "6" | "549" | "4" | "10531" | "CDKN1A |
| "REAC" | "Activated NTRK3 signals through PI3K" | "REAC:R-HSA-9603381" | "0.049880781927366426" | "1.3020667471726688" | "6" | "549" | "4" | "10531" | "IRS1 |
| "REAC" | "PTK6 Regulates Cell Cycle" | "REAC:R-HSA-8849470" | "0.049880781927366426" | "1.3020667471726688" | "6" | "549" | "4" | "10531" | "CCND1 |
| "WP" | "Gastrin Signaling Pathway" | "WP:WP4659" | "1.4809005052074642e-33" | "32.82947411871774" | "114" | "528" | "57" | "7399" | "CCND1 |
| "WP" | "Pancreatic adenocarcinoma pathway" | "WP:WP4263" | "2.0522598486151295e-24" | "23.68776765151586" | "88" | "528" | "43" | "7399" | "E2F3 |
| "WP" | "PI3K-Akt Signaling Pathway" | "WP:WP4172" | "4.4504026231893e-24" | "23.35160069708208" | "340" | "528" | "85" | "7399" | "CDK6 |
| "WP" | "Senescence and Autophagy in Cancer" | "WP:WP615" | "1.2865295831331619e-23" | "22.890580222944678" | "105" | "528" | "46" | "7399" | "CDKN1A |
| "WP" | "DNA Damage Response (only ATM dependent)" | "WP:WP710" | "2.3047780161529906e-23" | "22.6373708971734" | "111" | "528" | "47" | "7399" | "CCND1 |
| "WP" | "TGF-beta Signaling Pathway" | "WP:WP366" | "3.213161655307664e-23" | "22.49306742438872" | "132" | "528" | "51" | "7399" | "CCND1 |
| "WP" | "AGE/RAGE pathway" | "WP:WP2324" | "2.066146284394035e-22" | "21.684838933418497" | "66" | "528" | "36" | "7399" | "IRS1 |
| "WP" | "EGFR Tyrosine Kinase Inhibitor Resistance" | "WP:WP4806" | "4.452360662941382e-22" | "21.35140966293997" | "84" | "528" | "40" | "7399" | "CCND1 |
| "WP" | "Integrated Breast Cancer Pathway" | "WP:WP1984" | "6.053834401980523e-22" | "21.217969463011045" | "156" | "528" | "54" | "7399" | "WEE1 |
| "WP" | "Oncostatin M Signaling Pathway" | "WP:WP2374" | "1.6796153946605747e-21" | "20.774790153452116" | "65" | "528" | "35" | "7399" | "VEGFA |
| "WP" | "Signaling Pathways in Glioblastoma" | "WP:WP2261" | "3.179102443666231e-21" | "20.497695477117595" | "83" | "528" | "39" | "7399" | "CDK6 |
| "WP" | "Focal Adhesion" | "WP:WP306" | "4.3647219769761744e-21" | "20.360043414664155" | "198" | "528" | "60" | "7399" | "CCND1 |
| "WP" | "Hepatitis B infection" | "WP:WP4666" | "8.35699517186716e-21" | "20.077949848740097" | "152" | "528" | "52" | "7399" | "CDKN1A |
| "WP" | "Breast cancer pathway" | "WP:WP4262" | "1.6736454395117418e-20" | "19.776336541547693" | "154" | "528" | "52" | "7399" | "E2F3 |
| "WP" | "Leptin signaling pathway" | "WP:WP2034" | "1.185670366342845e-19" | "18.926036034392098" | "76" | "528" | "36" | "7399" | "CCND1 |
| "WP" | "Prolactin Signaling Pathway" | "WP:WP2037" | "1.185670366342845e-19" | "18.926036034392098" | "76" | "528" | "36" | "7399" | "PIK3R2 |
| "WP" | "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway" | "WP:WP3932" | "1.9750020876795423e-19" | "18.70443244096551" | "302" | "528" | "73" | "7399" | "CDKN1A |
| "WP" | "Epithelial to mesenchymal transition in colorectal cancer" | "WP:WP4239" | "2.3697981986843493e-19" | "18.62528863497272" | "162" | "528" | "52" | "7399" | "PIK3R2 |
| "WP" | "Small cell lung cancer" | "WP:WP4658" | "2.1859675905692255e-18" | "17.660356281243264" | "96" | "528" | "39" | "7399" | "E2F3 |
| "WP" | "Head and Neck Squamous Cell Carcinoma" | "WP:WP4674" | "9.922115579120777e-18" | "17.003395718331678" | "75" | "528" | "34" | "7399" | "CDK6 |
| "WP" | "Chromosomal and microsatellite instability in colorectal cancer " | "WP:WP4216" | "3.9573130180113614e-17" | "16.40259959627971" | "73" | "528" | "33" | "7399" | "CCND1 |
| "WP" | "Brain-Derived Neurotrophic Factor (BDNF) signaling pathway" | "WP:WP2380" | "7.168188233391758e-17" | "16.144590598818866" | "144" | "528" | "46" | "7399" | "EGR2 |
| "WP" | "EGF/EGFR Signaling Pathway" | "WP:WP437" | "3.9153334193117243e-16" | "15.407231248675876" | "162" | "528" | "48" | "7399" | "ITCH |
| "WP" | "Cell Cycle" | "WP:WP179" | "4.1312441915070475e-16" | "15.383919133784072" | "120" | "528" | "41" | "7399" | "WEE1 |
| "WP" | "Androgen receptor signaling pathway" | "WP:WP138" | "4.960774808122384e-16" | "15.304450487095957" | "88" | "528" | "35" | "7399" | "CCND1 |
| "WP" | "Insulin Signaling" | "WP:WP481" | "1.00256660750414e-15" | "14.998886764532658" | "159" | "528" | "47" | "7399" | "CRK |
| "WP" | "Adipogenesis" | "WP:WP236" | "1.2085479669253677e-15" | "14.917736107889684" | "129" | "528" | "42" | "7399" | "CDKN1A |
| "WP" | "ErbB Signaling Pathway" | "WP:WP673" | "1.775162036310326e-15" | "14.750761998516717" | "91" | "528" | "35" | "7399" | "CCND1 |
| "WP" | "IL-4 Signaling Pathway" | "WP:WP395" | "3.0447885124118876e-15" | "14.51644286759014" | "54" | "528" | "27" | "7399" | "PIK3R2 |
| "WP" | "VEGFA-VEGFR2 Signaling Pathway" | "WP:WP3888" | "5.243126961095962e-15" | "14.280409625819406" | "432" | "528" | "82" | "7399" | "CCND1 |
| "WP" | "Hepatitis C and Hepatocellular Carcinoma" | "WP:WP3646" | "1.0083738725628258e-14" | "13.99637841562232" | "56" | "528" | "27" | "7399" | "CCND1 |
| "WP" | "Kit receptor signaling pathway" | "WP:WP304" | "5.391901186543671e-14" | "13.268258075399304" | "59" | "528" | "27" | "7399" | "BCL2 |
| "WP" | "Human Thyroid Stimulating Hormone (TSH) signaling pathway" | "WP:WP2032" | "1.7220481168428522e-13" | "12.763954717814194" | "66" | "528" | "28" | "7399" | "CCNE1 |
| "WP" | "Integrated Cancer Pathway" | "WP:WP1971" | "1.9448963871541648e-13" | "12.711103530423522" | "48" | "528" | "24" | "7399" | "CDKN1A |
| "WP" | "Non-small cell lung cancer" | "WP:WP4255" | "2.7988036912213487e-13" | "12.553027561987278" | "72" | "528" | "29" | "7399" | "E2F3 |
| "WP" | "Endometrial cancer" | "WP:WP4155" | "4.156349909242109e-13" | "12.381287897771218" | "63" | "528" | "27" | "7399" | "CCND1 |
| "WP" | "Melanoma" | "WP:WP4685" | "4.391128731297899e-13" | "12.357423830836213" | "68" | "528" | "28" | "7399" | "E2F3 |
| "WP" | "Interferon type I signaling pathways" | "WP:WP585" | "4.942195217437794e-13" | "12.30608010389923" | "54" | "528" | "25" | "7399" | "CRK |
| "WP" | "Retinoblastoma Gene in Cancer" | "WP:WP2446" | "6.597186842595968e-13" | "12.18064121584992" | "90" | "528" | "32" | "7399" | "WEE1 |
| "WP" | "IL-2 Signaling Pathway" | "WP:WP49" | "8.658513184414939e-13" | "12.062556677410052" | "42" | "528" | "22" | "7399" | "BCL2 |
| "WP" | "IL-5 Signaling Pathway" | "WP:WP127" | "3.447155024758762e-12" | "11.462539185149241" | "40" | "528" | "21" | "7399" | "SPRED1 |
| "WP" | "Bladder Cancer" | "WP:WP2828" | "3.447155024758762e-12" | "11.462539185149241" | "40" | "528" | "21" | "7399" | "CCND1 |
| "WP" | "DNA Damage Response" | "WP:WP707" | "4.117878764448712e-12" | "11.385326443707788" | "68" | "528" | "27" | "7399" | "CDK6 |
| "WP" | "RAC1/PAK1/p38/MMP2 Pathway" | "WP:WP3303" | "4.117878764448712e-12" | "11.385326443707788" | "68" | "528" | "27" | "7399" | "CRK |
| "WP" | "T-Cell antigen Receptor (TCR) Signaling Pathway" | "WP:WP69" | "4.9415232718550084e-12" | "11.306139155006262" | "90" | "528" | "31" | "7399" | "CRK |
| "WP" | "Angiogenesis" | "WP:WP1539" | "2.5933503990639664e-11" | "10.586138799814194" | "24" | "528" | "16" | "7399" | "VEGFA |
| "WP" | "Interleukin-11 Signaling Pathway" | "WP:WP2332" | "4.029214340737849e-11" | "10.394779628982013" | "44" | "528" | "21" | "7399" | "BCL2 |
| "WP" | "PDGF Pathway" | "WP:WP2526" | "4.9168497994467954e-11" | "10.308313058390288" | "40" | "528" | "20" | "7399" | "RAF1 |
| "WP" | "Photodynamic therapy-induced AP-1 survival signaling." | "WP:WP3611" | "8.692119536747555e-11" | "10.060874309756842" | "50" | "528" | "22" | "7399" | "CCND1 |
| "WP" | "TGF-beta Receptor Signalling in Skeletal Dysplasias" | "WP:WP4816" | "9.629662672399979e-11" | "10.016388925968009" | "60" | "528" | "24" | "7399" | "TGFBR2 |
| "WP" | "Angiopoietin Like Protein 8 Regulatory Pathway" | "WP:WP3915" | "1.0235516551723433e-10" | "9.989890235082347" | "131" | "528" | "36" | "7399" | "CRK |
| "WP" | "T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection" | "WP:WP3863" | "1.483416787750071e-10" | "9.828736810408515" | "61" | "528" | "24" | "7399" | "RAF1 |
| "WP" | "TGF-beta Receptor Signaling" | "WP:WP560" | "1.5149107552500876e-10" | "9.819612951085142" | "56" | "528" | "23" | "7399" | "TGFBR2 |
| "WP" | "B Cell Receptor Signaling Pathway" | "WP:WP23" | "3.234138766427066e-10" | "9.49024134985923" | "97" | "528" | "30" | "7399" | "E2F3 |
| "WP" | "ESC Pluripotency Pathways" | "WP:WP3931" | "3.3781041708712835e-10" | "9.471326962184484" | "116" | "528" | "33" | "7399" | "PTEN |
| "WP" | "MET in type 1 papillary renal cell carcinoma" | "WP:WP4205" | "3.674567826218294e-10" | "9.434793731879251" | "58" | "528" | "23" | "7399" | "CDKN1A |
| "WP" | "MicroRNAs in cardiomyocyte hypertrophy" | "WP:WP1544" | "4.1123504977481093e-10" | "9.385909877293209" | "104" | "528" | "31" | "7399" | "PIK3R2 |
| "WP" | "IL-18 signaling pathway" | "WP:WP4754" | "4.1486180353588507e-10" | "9.382096548967665" | "273" | "528" | "54" | "7399" | "BCL2 |
| "WP" | "G1 to S cell cycle control" | "WP:WP45" | "5.103178586192283e-10" | "9.292159233227489" | "64" | "528" | "24" | "7399" | "WEE1 |
| "WP" | "Apoptosis" | "WP:WP254" | "8.287667158517907e-10" | "9.081567698974524" | "88" | "528" | "28" | "7399" | "BCL2 |
| "WP" | "Neovascularisation processes" | "WP:WP4331" | "1.4191761835926489e-9" | "8.847963685717733" | "37" | "528" | "18" | "7399" | "NOTCH1 |
| "WP" | "Spinal Cord Injury" | "WP:WP2431" | "1.8336267878695386e-9" | "8.736689054959792" | "116" | "528" | "32" | "7399" | "CCND1 |
| "WP" | "Notch Signaling Pathway Netpath" | "WP:WP61" | "1.8998203944313857e-9" | "8.721287454517867" | "62" | "528" | "23" | "7399" | "CCND1 |
| "WP" | "The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies" | "WP:WP4879" | "2.125736678036823e-9" | "8.672490533960563" | "57" | "528" | "22" | "7399" | "CDKN1A |
| "WP" | "Apoptosis-related network due to altered Notch3 in ovarian cancer" | "WP:WP2864" | "3.458592477031113e-9" | "8.461100607515336" | "53" | "528" | "21" | "7399" | "APP |
| "WP" | "IL-3 Signaling Pathway" | "WP:WP286" | "5.482203051523358e-9" | "8.26104488296598" | "49" | "528" | "20" | "7399" | "BCL2 |
| "WP" | "Estrogen signaling pathway" | "WP:WP712" | "5.588083075473152e-9" | "8.252737146052597" | "23" | "528" | "14" | "7399" | "BCL2 |
| "WP" | "Wnt Signaling Pathway and Pluripotency" | "WP:WP399" | "5.940799908016421e-9" | "8.226155074842257" | "101" | "528" | "29" | "7399" | "CCND1 |
| "WP" | "MAPK Signaling Pathway" | "WP:WP382" | "1.2315130240714498e-8" | "7.909560990846841" | "246" | "528" | "48" | "7399" | "CRK |
| "WP" | "Translation inhibitors in chronically activated PDGFRA cells" | "WP:WP4566" | "1.3394161073952823e-8" | "7.873084482680094" | "46" | "528" | "19" | "7399" | "PIK3R2 |
| "WP" | "Aryl Hydrocarbon Receptor Netpath" | "WP:WP2586" | "1.3394161073952823e-8" | "7.873084482680094" | "46" | "528" | "19" | "7399" | "CDKN1A |
| "WP" | "Viral Acute Myocarditis" | "WP:WP4298" | "1.764048415930974e-8" | "7.753489499429196" | "86" | "528" | "26" | "7399" | "CCND1 |
| "WP" | "Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway" | "WP:WP2203" | "2.1012449540559206e-8" | "7.677523316468975" | "47" | "528" | "19" | "7399" | "MTOR |
| "WP" | "Nonalcoholic fatty liver disease" | "WP:WP4396" | "2.1100137074810904e-8" | "7.6757147233449325" | "155" | "528" | "36" | "7399" | "ITCH |
| "WP" | "IL-7 Signaling Pathway" | "WP:WP205" | "2.665588284746774e-8" | "7.574206928992173" | "25" | "528" | "14" | "7399" | "CCND1 |
| "WP" | "Chemokine signaling pathway" | "WP:WP3929" | "2.837348392677861e-8" | "7.547087334726559" | "164" | "528" | "37" | "7399" | "CRK |
| "WP" | "Neural Crest Cell Migration during Development" | "WP:WP4564" | "4.843874358161003e-8" | "7.314807130241007" | "39" | "528" | "17" | "7399" | "PIK3CG |
| "WP" | "Ras Signaling" | "WP:WP4223" | "5.477142283925242e-8" | "7.261445976923878" | "183" | "528" | "39" | "7399" | "PIK3R2 |
| "WP" | "RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway" | "WP:WP2018" | "6.522329754976056e-8" | "7.185597247979279" | "55" | "528" | "20" | "7399" | "PIK3R2 |
| "WP" | "miRNA Regulation of DNA Damage Response" | "WP:WP1530" | "8.03352224618372e-8" | "7.095093999342659" | "98" | "528" | "27" | "7399" | "CDK6 |
| "WP" | "Netrin-UNC5B signaling Pathway" | "WP:WP4747" | "1.6408083720027296e-7" | "6.784942136705199" | "52" | "528" | "19" | "7399" | "VCAM1 |
| "WP" | "Neural Crest Differentiation" | "WP:WP2064" | "1.684690620044217e-7" | "6.773479842177869" | "101" | "528" | "27" | "7399" | "MYB |
| "WP" | "TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway" | "WP:WP2036" | "1.9748811723884736e-7" | "6.70445903053297" | "42" | "528" | "17" | "7399" | "RAF1 |
| "WP" | "Neural Crest Cell Migration in Cancer" | "WP:WP4565" | "1.9748811723884736e-7" | "6.70445903053297" | "42" | "528" | "17" | "7399" | "PIK3CG |
| "WP" | "Toll-like Receptor Signaling Pathway" | "WP:WP75" | "2.71089454583205e-7" | "6.566887376205571" | "103" | "528" | "27" | "7399" | "PIK3R2 |
